Patents slow innovation – case study of human gene patenting by Celera


Case study of public Human Genome Project vs private firm Celera on gene-level patents.

“Across a range of empirical specifications, I found evidence that Celera’s IP led to reductions in subsequent scientific research and product development on the order of 20 to 30 percent.”

http://dspace.mit.edu/handle/1721.1/78858#files-area

Heidi L. Williams. Journal of Political Economy Vol. 121, No. 1 (February 2013), pp. 1-27.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s